arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

4D Molecular Therapeutics, Inc.

FDMT Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$15.00
▲ +0.2% Today
as of Sep 4, 16:48 ET
Last 30 days +51.98% Jul 28 → Sep 04
$9.04 $11.11 $13.18 $15.26 $17.33 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$14.50
High
$15.00
Low
$14.33
Volume
$419,003
Avg Vol
$859,502
Mkt Cap
$889M
P/E (TTM)
Beta
52w High
$16.93
52w Low
$6.47
Div Yield
Shares Out
$55M

Recent Press Releases & News last 60 days · 2 items

Overview

52-week range
$6.47
$17
82% of range
Avg surprise (last 3)
-6.0%
Avg reaction (last 2)
-0.3%
50% positive
Latest IV / EM
75%
EM ±11.7% · $15 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.04$-0.84$-0.64$-0.44$-0.24 Actual $-0.88Actual $-0.77Actual $-0.24Actual $-0.66Actual $-0.63Actual $-0.79Actual $-0.86Est $-0.84Actual $-0.98Est $-0.88Actual $-1.01Actual $-1.01Est $-0.97Actual $-1.04 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-73M$-54M$-34M$-15M$4M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.04 financials
Thu May 7, 2026Mar/2026 $-1.01 $-0.97 -4.1% -17.4% -4.7% earnings
Tue Sep 30, 2025Sep 2025 $-1.01 financials
Mon Aug 11, 2025Jun/2025 $-0.98 $-0.88 -11.4% earnings
Thu May 8, 2025Mar/2025 $-0.86 $-0.84 -2.4% +4.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.79 financials
Sun Jun 30, 2024Jun 2024 $-0.63 financials
Sun Mar 31, 2024Mar 2024 $-0.66 financials
Sat Sep 30, 2023Sep 2023 $-0.24 financials
Fri Jun 30, 2023Jun 2023 $-0.77 financials
Fri Mar 31, 2023Mar 2023 $-0.88 financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$4M$3M$90,000$15,000$14,000$3,000
Cost of revenue
Gross profit
Operating income$-77M$-74M$-61M$-59M$-54M$-51M
Net income$-73M$-69M$-57M$-55M$-48M$-44M
EPS (diluted)$-1.04$-1.01$-1.01$-0.98$-0.86$-0.79

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$70M$72M$60M$49M$77M$134M$149M$188M
Inventory
Total current assets$383M$405M$413M$312M$303M$333M$435M$511M
Total assets$493M$513M$567M$424M$474M$516M$560M$604M
Long-term debt$20M$0
Total liabilities$85M$61M$61M$55M$53M$46M$50M$51M
Total equity$408M$452M$506M$369M$421M$470M$511M$553M

Implied volatility — last 90 days

54%185%317%448%580% Jun 08 — IV 136% · EM ±17.9%Jun 15 — IV 247% · EM ±17.9%Jun 19 — IV 167% · EM ±37.0%Jun 22 — IV 182% · EM ±37.9%Jun 23 — IV 62% · EM ±12.7%Jun 24 — IV 223% · EM ±44.8%Jun 25 — IV 222% · EM ±43.4%Jun 29 — IV 59% · EM ±10.5%Jun 30 — IV 105% · EM ±18.0%Jul 01 — IV 125% · EM ±20.9%Jul 02 — IV 76% · EM ±12.3%Jul 03 — IV 79% · EM ±12.3%Jul 20 — IV 228% · EM ±53.8%Jul 21 — IV 142% · EM ±33.0%Jul 22 — IV 100% · EM ±22.8%Jul 28 — IV 79% · EM ±16.2%Jul 29 — IV 75% · EM ±15.1%Jul 30 — IV 80% · EM ±15.6%Jul 31 — IV 264% · EM ±50.6%Aug 03 — IV 280% · EM ±49.6%Aug 04 — IV 283% · EM ±48.7%Aug 05 — IV 300% · EM ±50.1%Aug 06 — IV 293% · EM ±47.4%Aug 13 — IV 170% · EM ±20.1%Aug 17 — IV 293% · EM ±24.5%Aug 20 — IV 580% · EM ±24.2%Aug 25 — IV 80% · EM ±16.4%Aug 26 — IV 55% · EM ±10.9%Aug 27 — IV 119% · EM ±23.3%Aug 28 — IV 80% · EM ±15.3%Aug 31 — IV 63% · EM ±11.2%Sep 01 — IV 137% · EM ±23.5%Sep 02 — IV 86% · EM ±14.4%Sep 03 — IV 69% · EM ±11.2%Sep 04 — IV 75% · EM ±11.7%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.